Crinetics Pharmaceuticals Inc
(CRNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 0 | 367 | 781 | 548 | 657 |
| Gross Profit | N/A | 367 | 781 | 548 | 657 |
| Operating Expenses | 13,345 | 10,411 | 10,212 | 8,618 | 6,340 |
| Operating Income | -13,345 | -10,044 | -9,431 | -8,070 | -5,683 |
| Other Income | 918 | 1,028 | 936 | 482 | 115 |
| Pre-tax Income | -12,427 | -9,016 | -8,495 | -7,588 | -5,568 |
| Net Income Continuous | -12,427 | -9,016 | -8,495 | -7,588 | -5,568 |
| Net Income | $-12,427 | $-9,016 | $-8,495 | $-7,588 | $-5,568 |
| EPS Basic Total Ops | -0.51 | -0.37 | 3.48 | -0.38 | -2.41 |
| EPS Basic Continuous Ops | -0.51 | -0.37 | 3.48 | -0.38 | -2.41 |
| EPS Diluted Total Ops | -0.51 | -0.37 | 3.48 | -0.38 | -2.41 |
| EPS Diluted Continuous Ops | -0.51 | -0.37 | 3.48 | -0.38 | -2.41 |
| EBITDA(a) | $-13,404 | $-10,244 | $-9,656 | $-7,931 | $-5,607 |